PubMed Health⌕ Search

PubMed · 15115367

Recycling in a megacity.

Abstract

In the aftermath of the 9/11 disaster, Mayor Bloomberg of New York City unveiled an aggressive budget plan that included the temporary suspension of glass and plastics recycling. This was considered by many to be anti-environmental, but the results of this study show that for lack of markets, even at zero or negative prices, nearly 90% of the plastic and glass set aside by thoughtful New Yorkers was transported to materials recovery facilities (MRFs) and from there to landfills. Sending bales of plastics to landfills is not limited to New York City. It is an environmental paradox that the United States is digging up new oil fields in pristine areas and, at the same time, continues to convert greenfields to brownfields by burying nearly 20 million tons of plastic fuel annually. The study also determined that at the present rate of source separation, estimated to be less than 30% of the available recyclables in 1999, building large, modern MRFs may increase substantially the rate of New York City recycling and also allow single-stream collection of commingled recyclables, as is done in Phoenix, AZ. Single-stream collection simplifies separation at the source by citizens and increases the amount of collected recyclables. Also, because collection represents a large fraction of the costs of waste management, it may have a significant economic advantage.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nickolas J Themelis, Claire E Todd. 2004. Recycling in a megacity.. https://doi.org/10.1080/10473289.2004.10470921

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

ACOG Committee Opinion No. 359: commercial enterprises in medical practice.

Increasing numbers of physicians sell and promote both medical and nonmedical products as part of their practices. Physicians always have rendered advice and treatment for a fee, and this practice is appropriate. It is unethical under most circumstances, however, for physicians to sell or promote medical or nonmedical products or services for their financial benefit. The following activities are considered unethical: sale of prescription drugs to be used at home, sale or promotion of nonprescription medicine, sale or promotion of presumptively therapeutic agents that generally are not accepted as part of standard medical practice, sale or promotion of non-health-related items, recruitment of patients or other health care professionals into multilevel marketing arrangements, and sale or promotion of any product in whose sale the physician has a significant financial interest. It is ethical and appropriate, however, to sell products to patients as follows: sale of devices or drugs that require professional administration in the office setting; sale of therapeutic agents, when no other facilities can provide them at reasonable convenience and at reasonable cost; sale of products that clearly are external to the patient-physician relationship, when such a sale would be considered appropriate in an external relationship; and sale of low-cost products for the benefit of community organizations. A rationale is provided for both the prohibited activities and exceptions.

Commerce↗